Search Results - "Raghinaru, Dan"

Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry by Wong, Jenise C, Foster, Nicole C, Maahs, David M, Raghinaru, Dan, Bergenstal, Richard M, Ahmann, Andrew J, Peters, Anne L, Bode, Bruce W, Aleppo, Grazia, Hirsch, Irl B, Kleis, Lora, Chase, H Peter, DuBose, Stephanie N, Miller, Kellee M, Beck, Roy W, Adi, Saleh

“…To assess the frequency of continuous glucose monitoring (CGM) device use, factors associated with its use, and the relationship of CGM with diabetes outcomes…”
Get full text

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis by Buckingham, Bruce A, Raghinaru, Dan, Cameron, Fraser, Bequette, B Wayne, Chase, H Peter, Maahs, David M, Slover, Robert, Wadwa, R Paul, Wilson, Darrell M, Ly, Trang, Aye, Tandy, Hramiak, Irene, Clarson, Cheril, Stein, Robert, Gallego, Patricia H, Lum, John, Sibayan, Judy, Kollman, Craig, Beck, Roy W

“…Nocturnal hypoglycemia can cause seizures and is a major impediment to tight glycemic control, especially in young children with type 1 diabetes. We conducted…”
Get full text

Multinational Home Use of Closed-Loop Control Is Safe and Effective by Anderson, Stacey M, Raghinaru, Dan, Pinsker, Jordan E, Boscari, Federico, Renard, Eric, Buckingham, Bruce A, Nimri, Revital, Doyle, 3rd, Francis J, Brown, Sue A, Keith-Hynes, Patrick, Breton, Marc D, Chernavvsky, Daniel, Bevier, Wendy C, Bradley, Paige K, Bruttomesso, Daniela, Del Favero, Simone, Calore, Roberta, Cobelli, Claudio, Avogaro, Angelo, Farret, Anne, Place, Jerome, Ly, Trang T, Shanmugham, Satya, Phillip, Moshe, Dassau, Eyal, Dasanayake, Isuru S, Kollman, Craig, Lum, John W, Beck, Roy W, Kovatchev, Boris

“…To evaluate the efficacy of a portable, wearable, wireless artificial pancreas system (the Diabetes Assistant [DiAs] running the Unified Safety System) on…”
Get full text

Late Outcomes of a Single-Center Experience of 400 Consecutive Thoracic Endovascular Aortic Repairs by LEE, W. Anthony, DANIELS, Michael J, BEAVER, Thomas M, KLODELL, Charles T, RAGHINARU, Dan E, HESS, Philip J

“…In this study, we report the late outcomes of a large, decade-long single-center thoracic endovascular aortic repair experience. A prospectively maintained…”
Get full text

Predictive hyperglycemia and hypoglycemia minimization: In‐home double‐blind randomized controlled evaluation in children and young adolescents by Forlenza, Gregory P, Raghinaru, Dan, Cameron, Faye, Wayne Bequette, B, Peter Chase, H, Paul Wadwa, R, Maahs, David M, Jost, Emily, Ly, Trang T, Wilson, Darrell M, Norlander, Lisa, Ekhlaspour, Laya, Min, Hyojin, Clinton, Paula, Njeru, Nelly, Lum, John W, Kollman, Craig, Beck, Roy W, Buckingham, Bruce A

“…Objective The primary objective of this trial was to evaluate the feasibility, safety, and efficacy of a predictive hyperglycemia and hypoglycemia minimization…”
Get full text

Prediction of graft patency and mortality after distal revascularization and interval ligation for hemodialysis access-related hand ischemia by Scali, Salvatore T., MD, Chang, Catherine K., MD, Raghinaru, Dan, MS, Daniels, Michael J., ScD, Beck, Adam W., MD, Feezor, Robert J., MD, Berceli, Scott A., MD, PhD, Huber, Thomas S., MD, PhD

“…Objective The treatment goals of access-related hand ischemia (ARHI) are to reverse symptoms and salvage the access. Many procedures have been described, but…”
Get full text

Donor Age and Factors Related to Endothelial Cell Loss 10 Years after Penetrating Keratoplasty by Lass, Jonathan H., MD, Benetz, Beth Ann, MA, Gal, Robin L., MSPH, Kollman, Craig, PhD, Raghinaru, Dan, MS, Dontchev, Mariya, MPH, Mannis, Mark J., MD, Holland, Edward J., MD, Chow, Christopher, MD, McCoy, Kristen, BS, Price, Francis W., MD, Sugar, Alan, MD, Verdier, David D., MD, Beck, Roy W., MD, PhD

“…Objective To examine the effect of donor age and other perioperative factors on long-term endothelial cell loss after penetrating keratoplasty (PKP). Design…”
Get full text

The Effect of Donor Age on Penetrating Keratoplasty for Endothelial Disease by Mannis, Mark J., MD, Holland, Edward J., MD, Gal, Robin L., MSPH, Dontchev, Mariya, MPH, Kollman, Craig, PhD, Raghinaru, Dan, MS, Dunn, Steven P., MD, Schultze, Robert L., MD, Verdier, David D., MD, Lass, Jonathan H., MD, Raber, Irving M., MD, Sugar, Joel, MD, Gorovoy, Mark S., MD, Sugar, Alan, MD, Stulting, R. Doyle, MD, PhD, Montoya, Monty M., MBA, Penta, Jeffrey G., MBA, Benetz, Beth Ann, MA, Beck, Roy W., MD, PhD

“…Objective To determine whether the 10-year success rate of penetrating keratoplasty for corneal endothelial disorders is associated with donor age. Design…”
Get full text

First Look at Control-IQ: A New-Generation Automated Insulin Delivery System by Brown, Sue, Raghinaru, Dan, Emory, Emma, Kovatchev, Boris

“…To pilot test a new closed-loop control technology to validate it for a further large clinical trial. The t:slim X2 insulin pump with Control-IQ Technology…”
Get full text

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes by Brown, Sue A, Kovatchev, Boris P, Raghinaru, Dan, Lum, John W, Buckingham, Bruce A, Kudva, Yogish C, Laffel, Lori M, Levy, Carol J, Pinsker, Jordan E, Wadwa, R. Paul, Dassau, Eyal, Doyle, Francis J, Anderson, Stacey M, Church, Mei Mei, Dadlani, Vikash, Ekhlaspour, Laya, Forlenza, Gregory P, Isganaitis, Elvira, Lam, David W, Kollman, Craig, Beck, Roy W

“…Closed-loop systems that automate insulin delivery may improve glycemic outcomes in patients with type 1 diabetes. In this 6-month randomized, multicenter…”
Get full text

Glycemic Outcomes in Baseline Hemoglobin A1C Subgroups in the International Diabetes Closed-Loop Trial by Ekhlaspour, Laya, Town, Marissa, Raghinaru, Dan, Lum, John W, Brown, Sue A, Buckingham, Bruce A

“…Using a closed-loop system significantly improves time in range (TIR) 70-180 mg/dL in patients with type 1 diabetes (T1D). In a 6-month RCT, 112 subjects were…”
Get more information

The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring by Beck, Roy W, Raghinaru, Dan, Calhoun, Peter, Bergenstal, Richard M

“…While it is recognized that there is a strong relationship between the amount of time glucose levels are <70 mg/dL (T ) and the amount of time <54 mg/dL (T ),…”
Get more information

The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial by Raghinaru, Dan, Calhoun, Peter, Bergenstal, Richard M, Beck, Roy W

“…To determine the optimal duration of a run-in period for initiation of real-time continuous glucose monitoring (CGM) before the start of a randomized…”
Get more information

387-P: Glycemic Outcomes in Baseline Hemoglobin A1c Subgroups in the International Diabetes Closed-Loop (IDCL) Trial by EKHLASPOUR, LAYA, RAGHINARU, DAN, LUM, JOHN, BROWN, SUE A., BUCKINGHAM, BRUCE A.

“…Using a closed loop system significantly improves time in range (TIR) in patients with type 1 diabetes (T1D). In a 6-month RCT, 112 subjects were assigned to…”
Get full text

Donor age and factors related to endothelial cell loss 10 years after penetrating keratoplasty: Specular Microscopy Ancillary Study by Lass, Jonathan H, Benetz, Beth Ann, Gal, Robin L, Kollman, Craig, Raghinaru, Dan, Dontchev, Mariya, Mannis, Mark J, Holland, Edward J, Chow, Christopher, McCoy, Kristen, Price, Jr, Francis W, Sugar, Alan, Verdier, David D, Beck, Roy W

“…To examine the effect of donor age and other perioperative factors on long-term endothelial cell loss after penetrating keratoplasty (PKP). Multicenter,…”
Get full text

118-LB: Glucose Variability throughout the Menstrual Cycle on Closed-Loop Control in Type 1 DM by LEVY, CAROL J., OMALLEY, GRENYE, BROWN, SUE A., RAGHINARU, DAN, KUDVA, YOGISH C., DASSAU, EYAL, KOVATCHEV, BORIS, ANDERSON, STACEY

“…Many women with type 1 DM report change in glucose (GLU) control and insulin (INS) dosing throughout the menstrual cycle (MC). No trials have reported the…”
Get full text

Randomized Controlled Trial of Mobile Closed-Loop Control by Kovatchev, Boris, Anderson, Stacey M, Raghinaru, Dan, Kudva, Yogish C, Laffel, Lori M, Levy, Carol, Pinsker, Jordan E, Wadwa, R Paul, Buckingham, Bruce, Doyle, 3rd, Francis J, Brown, Sue A, Church, Mei Mei, Dadlani, Vikash, Dassau, Eyal, Ekhlaspour, Laya, Forlenza, Gregory P, Isganaitis, Elvira, Lam, David W, Lum, John, Beck, Roy W

“…Assess the efficacy of inControl AP, a mobile closed-loop control (CLC) system. This protocol, NCT02985866, is a 3-month parallel-group, multicenter,…”
Get full text

149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes by GAL, ROBIN L., RAGHINARU, DAN, ALEPPO, GRAZIA, OLSON, BETH A., KRUGER, DAVIDA F., BERGENSTAL, RICHARD M., WEINSTOCK, RUTH S., BRADSHAW, AMY, MCARTHUR, TERESA S., OSER, SEAN, OSER, TAMARA, HOOD, KOREY K., CUSHMAN, TERRA L., JOHNSON, MARY L., KOLLMAN, CRAIG, BECK, ROY

“…The impact of a telemedicine model for a virtual diabetes clinic was assessed 6 months following completion of a 6-month intervention of education and support…”
Get full text

263-OR: Older Adults Benefit from Virtual Support for CGM Use but Require Longer Visits by WEINSTOCK, RUTH S., THOMPSON, ZACHARY, BERGENSTAL, RICHARD M., CUSHMAN, TERRA L., GAL, ROBIN L., KOLLMAN, CRAIG, KRUGER, DAVIDA F., HOOD, KOREY K., JOHNSON, MARY L., MCARTHUR, TERESA S., OLSON, BETH A., OSER, SEAN, OSER, TAMARA, RAGHINARU, DAN, BECK, ROY, ALEPPO, GRAZIA

“…The Virtual Diabetes Specialty Clinic (VDiSC) provided type 1 (T1D) and type 2 diabetes (T2D) adults taking insulin virtual care with remote CGM training and…”
Get full text

1031-P: Virtual Clinic Support—Patient-Reported Outcome Benefits by HOOD, KOREY K., BERGENSTAL, RICHARD M., CUSHMAN, TERRA L., GAL, ROBIN L., KOLLMAN, CRAIG, KRUGER, DAVIDA F., JOHNSON, MARY L., MCARTHUR, TERESA S., OLSON, BETH A., OSER, SEAN, OSER, TAMARA, RAGHINARU, DAN, THOMPSON, ZACHARY, WEINSTOCK, RUTH S., BECK, ROY, ALEPPO, GRAZIA

“…Behavioral health support can benefit those living with diabetes, but there is limited information on patient reported outcomes (PROs) associated with a…”
Get full text